Allan R. Li

Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors

Marissa N. Balak, Yixuan Gong, Gregory J. Riely et al. · Clinical Cancer Research · 2006 · 824 citations

Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib

Gregory J. Riely, William Pao, DuyKhanh Pham et al. · Clinical Cancer Research · 2006 · 740 citations

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

Rohit Bhargava, William L. Gerald, Allan R. Li et al. · Modern Pathology · 2005 · 355 citations

Breast Oncology, Medicine, Pathology +8

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

Vincent A. Miller, Gregory J. Riely, Maureen F. Zakowski et al. · Journal of Clinical Oncology · 2008 · 299 citations

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

Jenifer L. Marks, Stephen Broderick, Qin Zhou et al. · Journal of Thoracic Oncology · 2008 · 272 citations · Full text

Kras Mutations, Surgical Oncology, Medicine +9